Eli Lilly and Walmart Partner to Expand Access to Weight-Loss Drug Zepbound

Gelonghui October 29 | Eli Lilly and Company is collaborating with Walmart to expand the sales reach of the weight-loss drug Zepbound, which will be available in Walmart pharmacies across China by mid-November. Walmart pharmacies will offer all approved dosages of Zepbound, with the lowest dose starting at $349 per month for self-pay.